https://www.selleckchem.com/pr....oducts/nvp-dky709.ht
PURPOSE To evaluate adverse events of fluorescein angiography (FA) in pediatric patients. DESIGN Single-institution retrospective chart review. PARTICIPANTS Patients 0 to 18 years of age who underwent FA between January 2010 and December 2015 at a single institution in the United States. METHODS Pediatric patients who underwent FA by 3 surgeons were included in the study. Patients with fewer than 24 hours of documented follow-up were excluded. Significant adverse events within 24 hours of FA were evaluated. Detailed intraoperative an
Like
Comment
Share
